Khurram Jamil insider trades

Open-market stock purchases and sales by Khurram Jamil, Chief Medical Officer at Galectin Therapeutics Inc, from SEC Form 4 filings since Aug 1, 2024.

Recent trades

DateStockTradeValue
Jul 14, 2026GALT Galectin Therapeutics IncSold$83.3K
Jul 14, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jun 29, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jun 29, 2026GALT Galectin Therapeutics IncSold$239K
Jun 26, 2026GALT Galectin Therapeutics IncSold$10.2K
Jun 26, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jun 26, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jun 26, 2026GALT Galectin Therapeutics IncSold$12.7K
Jun 23, 2026GALT Galectin Therapeutics IncSold$23.7K
Jun 23, 2026GALT Galectin Therapeutics IncBought (not open market)—
May 26, 2026GALT Galectin Therapeutics IncSold$1.8K
May 26, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 6, 2026GALT Galectin Therapeutics IncSold$78.2K
Jan 5, 2026GALT Galectin Therapeutics IncSold$99.4K
Jan 2, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 2, 2026GALT Galectin Therapeutics IncSold$54.8K
Jan 1, 2026GALT Galectin Therapeutics IncBought (not open market)—
Dec 31, 2025GALT Galectin Therapeutics IncBought (not open market)—
Dec 31, 2025GALT Galectin Therapeutics IncSold$33.1K
Dec 17, 2025GALT Galectin Therapeutics IncBought (not open market)—
Dec 17, 2025GALT Galectin Therapeutics IncSold$31.5K
Dec 17, 2025GALT Galectin Therapeutics IncSold$45.5K
Dec 17, 2025GALT Galectin Therapeutics IncSold$59.8K

Companies traded

  • GALT Galectin Therapeutics Inc: 17 sales, last Jul 14, 2026

Get free alerts when Khurram Jamil files a new trade →